Literature DB >> 21631360

The effects of powdered fertilized eggs on depression.

Ester Solberg1.   

Abstract

This 12-week, double-blind, placebo-controlled study investigated the effects of fertilized egg powder (Young Tissue Extract; YT®) intake on outcome measures for depression. Fifty-five patients with depression were randomly assigned to receive YTE, YTE plus Melissa officinalis, or placebo for 12 weeks. At baseline, there were no significant differences in scores on the Hamilton Depression Rating Scale (HAM-D) or Beck Depression Inventory II (BDI-II) among the 3 groups. At 12 weeks, the HAM-D scores in groups treated with YTE or YTE with M. officinalis were both significantly lower than those in the placebo group. In addition, both treatment groups showed a significant improvement in depression as measured by the change in HAM-D scores from baseline to 12 weeks, whereas the placebo group showed no significant change. There were no significant differences between the 2 treatment groups. The study indicates that the fertilized egg powder has an antidepressive effect and may be an alternative or adjunct to antidepressive medication for some patients, but further research is necessary.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21631360      PMCID: PMC3133680          DOI: 10.1089/jmf.2010.0146

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  18 in total

Review 1.  Advances in the value of eggs and egg components for human health.

Authors:  Jennifer Kovacs-Nolan; Marshall Phillips; Yoshinori Mine
Journal:  J Agric Food Chem       Date:  2005-11-02       Impact factor: 5.279

Review 2.  Complementary and alternative medicine for the treatment of depressive disorders in women.

Authors:  Kristina M Deligiannidis; Marlene P Freeman
Journal:  Psychiatr Clin North Am       Date:  2010-06

3.  Sexual desire in men: effects of oral ingestion of a product derived from fertilized eggs.

Authors:  B Eskeland; E Thom; K O Svendsen
Journal:  J Int Med Res       Date:  1997 Mar-Apr       Impact factor: 1.671

Review 4.  Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence.

Authors:  David Mischoulon; Maurizio Fava
Journal:  Am J Clin Nutr       Date:  2002-11       Impact factor: 7.045

5.  Complementary and alternative medicine use by psychiatric inpatients.

Authors:  Gary Elkins; M Hasan Rajab; Joel Marcus
Journal:  Psychol Rep       Date:  2005-02

Review 6.  Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability.

Authors:  David Wheatley
Journal:  J Psychopharmacol       Date:  2005-07       Impact factor: 4.153

Review 7.  Definition and epidemiology of treatment-resistant depression.

Authors:  M Fava; K G Davidson
Journal:  Psychiatr Clin North Am       Date:  1996-06

8.  Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm).

Authors:  David O Kennedy; Wendy Little; Andrew B Scholey
Journal:  Psychosom Med       Date:  2004 Jul-Aug       Impact factor: 4.312

9.  Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties.

Authors:  D O Kennedy; G Wake; S Savelev; N T J Tildesley; E K Perry; K A Wesnes; A B Scholey
Journal:  Neuropsychopharmacology       Date:  2003-10       Impact factor: 7.853

10.  Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm).

Authors:  D O Kennedy; Andrew B Scholey; N T J Tildesley; E K Perry; K A Wesnes
Journal:  Pharmacol Biochem Behav       Date:  2002-07       Impact factor: 3.533

View more
  1 in total

1.  A double-blind, randomized pilot study for comparison of Melissa officinalis L. and Lavandula angustifolia Mill. with Fluoxetine for the treatment of depression.

Authors:  Mostafa Araj-Khodaei; Ahmad Ali Noorbala; Reza Yarani; Fatemeh Emadi; Elham Emaratkar; Soghrat Faghihzadeh; Zahra Parsian; Fatemeh Alijaniha; Mohammad Kamalinejad; Mohsen Naseri
Journal:  BMC Complement Med Ther       Date:  2020-07-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.